Have a personal or library account? Click to login
Effects of Bismuth Oxide Nanoparticles, Cisplatin and Baicalein-rich Fraction on ROS Generation in Proton Beam irradiated Human Colon Carcinoma Cells Cover

Effects of Bismuth Oxide Nanoparticles, Cisplatin and Baicalein-rich Fraction on ROS Generation in Proton Beam irradiated Human Colon Carcinoma Cells

Open Access
|Mar 2022

Authors

Noor Nabilah Talik Sisin

School of Health Sciences, Universiti Sains Malaysia, Kelantan, Malaysia

Hiroaki Akasaka

Division of Radiation Oncology, Kobe University Graduate School of Medicine, Kobe, Japan

Ryohei Sasaki

Division of Radiation Oncology, Kobe University Graduate School of Medicine, Kobe, Japan

Takahiro Tominaga

Faculty of Health Sciences, Hiroshima International University, Hiroshima, Japan

Hayato Miura

Hyogo Ion Beam Medical Centre, Hyogo, Japan

Masashi Nishi

Hyogo Ion Beam Medical Centre, Hyogo, Japan

Moshi Geso

Medical Radiation Discipline, School Medical Sciences, RMIT University, Victoria, Australia

Nor Fazila Che Mat

School of Health Sciences, Universiti Sains Malaysia, Kelantan, Malaysia

Khairunisak Abdul Razak

School of Materials and Mineral Resources Engineering, Universiti Sains Malaysia, Penang, Malaysia

Wan Nordiana Rahman

wandiana@usm.my

School of Health Sciences, Universiti Sains Malaysia, Kelantan, Malaysia
DOI: https://doi.org/10.2478/pjmpe-2022-0004 | Journal eISSN: 1898-0309 | Journal ISSN: 1425-4689
Language: English
Page range: 30 - 36
Submitted on: Dec 12, 2021
Accepted on: Mar 6, 2022
Published on: Mar 29, 2022
Published by: Polish Society of Medical Physics
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Noor Nabilah Talik Sisin, Hiroaki Akasaka, Ryohei Sasaki, Takahiro Tominaga, Hayato Miura, Masashi Nishi, Moshi Geso, Nor Fazila Che Mat, Khairunisak Abdul Razak, Wan Nordiana Rahman, published by Polish Society of Medical Physics
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.